Global Clinical Trial Imaging Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Description

According to our latest research, the global Clinical Trial Imaging market size will reach USD 2550 million in 2031, growing at a CAGR of 6.8% over the analysis period.

Clinical trial imaging refers to the process of using imaging technology (such as X-ray, CT, MRI, etc.) to observe and analyze the subjects in vivo during clinical trials. It plays an irreplaceable role in evaluating the efficacy, safety and side effects of new drugs, treatments or medical devices. Through imaging technology, researchers can intuitively observe the distribution, metabolism and mechanism of action of drugs in the body, providing a scientific basis for the clinical application of drugs.,The core manufacturers of clinical trial imaging in the world include Clario, ICON, McLaren, Calyx and BioTelemetry. The top five companies hold about 60% of the shares. North America is the largest market, with a share of about 33%, followed by Europe and Asia Pacific, each with a share of about 27%. In terms of product type, central imaging services are the largest market segment, with a share of about 70%. In terms of application, the largest application is pharmaceutical companies, followed by biotechnology companies.

In the process of clinical trial imaging, ethical principles and regulatory requirements must be strictly followed. Researchers need to ensure that the informed consent rights of subjects are fully guaranteed and that scientific principles and ethical standards are strictly followed during the trial. At the same time, regulatory agencies also need to strengthen the supervision of clinical trial imaging to ensure the reliability and validity of trial results.

Clinical trial imaging plays an important role in different stages of drug development. For example, in Phase I clinical trials, imaging technology can be used to observe the pharmacokinetic characteristics of drugs in the human body; in Phase II/III clinical trials, the efficacy and safety of drugs can be evaluated.

For new medical devices, clinical trial imaging can be used to evaluate their performance, safety and clinical application value. By comparing the effects of using new equipment with existing equipment, strong support can be provided for the promotion and application of medical equipment.

In clinical trials, imaging technology can also be used for early diagnosis of diseases, disease monitoring and evaluation of treatment effects. For example, in tumor treatment, regular imaging examinations can be used to observe the size, morphology and changes of tumors, so as to adjust the treatment plan in time.

With the continuous advancement of medical technology and the increasing demand for clinical trials, the clinical trial imaging market will usher in a broader development prospect. In the future, this field will pay more attention to the development of technological innovation and personalized services to meet the needs of different clinical trials.

The driving factors of the clinical trial imaging market mainly include the following:
Technological progress: innovation drives core growth
High-precision and multimodal imaging technology
Breakthroughs in technologies such as MRI, CT, and PET: High-resolution imaging technology (such as 3T MRI and ultra-low-dose CT) provides more accurate anatomical and functional information, which helps early diagnosis of diseases and efficacy evaluation.

Multimodal fusion: The fusion technology of CT and MRI, PET and CT, combined with anatomical and metabolic information, significantly improves diagnostic sensitivity, such as in tumor staging.

Artificial Intelligence and Automation
AI-assisted analysis: Deep learning algorithms can automatically detect lesions (such as lung nodules and breast calcifications), reduce human errors, and improve diagnostic efficiency.

Process Automation: AI optimizes scanning protocols and automatically generates reports, shortens clinical trial cycles, and reduces costs.

Portable and Real-time Imaging
Portable ultrasound equipment: Suitable for bedside examinations and remote areas, expanding the coverage of clinical trials.

Real-time imaging technology: such as ultrasound elastic imaging, dynamically monitors changes in tissue hardness, and provides instant feedback for diseases such as liver fibrosis.

Policy support: Create a favorable development environment
Improvement of regulatory framework
FDA, NMPA and other agencies: Ensure the safety and effectiveness of equipment through strict approval processes, such as requiring that Class III medical imaging equipment must pass clinical trials before registration.

International Standard Coordination: Promote imaging protocols and data standardization (such as DICOM format) and promote multi-center trial data sharing.

Funding and Incentives
Government research funding: For example, China's "14th Five-Year Plan" special support for medical imaging technology to accelerate technology transformation.

Tax incentives and subsidies: Encourage corporate R&D and innovation, such as providing financial subsidies for localization projects of high-end imaging equipment.

Growth in medical demand: changes in population and disease structure
Aging and chronic disease burden
High incidence of cancer and neurodegenerative diseases: The global incidence of cancer is rising, driving the demand for early screening and efficacy monitoring.

Demand for precision medicine: Individualized treatment relies on high-precision imaging (such as molecular imaging in tumor targeted therapy).

New drug development and clinical trial expansion
Innovative drug development boom: The number of new drugs under development has surged globally, and the demand for imaging in clinical trials has increased accordingly.

Rare diseases and real-world research: Imaging technology helps small sample size trials and long-term efficacy tracking.

The growth of the clinical trial imaging market is the result of technological innovation, policy dividends, demand upgrades and the evolution of the competitive landscape. In the future, with the deep integration of AI, multimodal imaging and cloud technology, the market will accelerate its development towards intelligence and precision. At the same time, the rise of local companies will reshape the global competitive landscape and inject new vitality into the industry.

This report is a detailed and comprehensive analysis for global Clinical Trial Imaging market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:
Global Clinical Trial Imaging market size and forecasts, in consumption value ($ Million), 2020-2031
Global Clinical Trial Imaging market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Clinical Trial Imaging market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Clinical Trial Imaging market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Clinical Trial Imaging
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Clinical Trial Imaging market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ICON, ERT, McLaren, Bioclinica, Parexel, BioTelemetry, ProScan Imaging, Imaging Endpoints, Radiant Sage, Micron, Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Clinical Trial Imaging market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    In-house Imaging Service
    Central Imaging Service

Market segment by Application
    Pharmaceutical Companies
    Biotechnology Companies
    Academic Institutes
    Others

Market segment by players, this report covers
    ICON
    ERT
    McLaren
    Bioclinica
    Parexel
    BioTelemetry
    ProScan Imaging
    Imaging Endpoints
    Radiant Sage
    Micron, Inc.
    Intrinsic Imaging
    Median Technologies
    Cardiovascular Imaging Technologies
    Banook Medical
    IXICO
    Tigermed
    Runda Medical
    Konica Minolta
    Keosys

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Clinical Trial Imaging product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Clinical Trial Imaging, with revenue, gross margin, and global market share of Clinical Trial Imaging from 2020 to 2025.
Chapter 3, the Clinical Trial Imaging competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Clinical Trial Imaging market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Clinical Trial Imaging.
Chapter 13, to describe Clinical Trial Imaging research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Clinical Trial Imaging by Type
        1.3.1 Overview: Global Clinical Trial Imaging Market Size by Type: 2020 Versus 2024 Versus 2031
        1.3.2 Global Clinical Trial Imaging Consumption Value Market Share by Type in 2024
        1.3.3 In-house Imaging Service
        1.3.4 Central Imaging Service
    1.4 Global Clinical Trial Imaging Market by Application
        1.4.1 Overview: Global Clinical Trial Imaging Market Size by Application: 2020 Versus 2024 Versus 2031
        1.4.2 Pharmaceutical Companies
        1.4.3 Biotechnology Companies
        1.4.4 Academic Institutes
        1.4.5 Others
    1.5 Global Clinical Trial Imaging Market Size & Forecast
    1.6 Global Clinical Trial Imaging Market Size and Forecast by Region
        1.6.1 Global Clinical Trial Imaging Market Size by Region: 2020 VS 2024 VS 2031
        1.6.2 Global Clinical Trial Imaging Market Size by Region, (2020-2031)
        1.6.3 North America Clinical Trial Imaging Market Size and Prospect (2020-2031)
        1.6.4 Europe Clinical Trial Imaging Market Size and Prospect (2020-2031)
        1.6.5 Asia-Pacific Clinical Trial Imaging Market Size and Prospect (2020-2031)
        1.6.6 South America Clinical Trial Imaging Market Size and Prospect (2020-2031)
        1.6.7 Middle East & Africa Clinical Trial Imaging Market Size and Prospect (2020-2031)

2 Company Profiles
    2.1 ICON
        2.1.1 ICON Details
        2.1.2 ICON Major Business
        2.1.3 ICON Clinical Trial Imaging Product and Solutions
        2.1.4 ICON Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.1.5 ICON Recent Developments and Future Plans
    2.2 ERT
        2.2.1 ERT Details
        2.2.2 ERT Major Business
        2.2.3 ERT Clinical Trial Imaging Product and Solutions
        2.2.4 ERT Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.2.5 ERT Recent Developments and Future Plans
    2.3 McLaren
        2.3.1 McLaren Details
        2.3.2 McLaren Major Business
        2.3.3 McLaren Clinical Trial Imaging Product and Solutions
        2.3.4 McLaren Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.3.5 McLaren Recent Developments and Future Plans
    2.4 Bioclinica
        2.4.1 Bioclinica Details
        2.4.2 Bioclinica Major Business
        2.4.3 Bioclinica Clinical Trial Imaging Product and Solutions
        2.4.4 Bioclinica Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.4.5 Bioclinica Recent Developments and Future Plans
    2.5 Parexel
        2.5.1 Parexel Details
        2.5.2 Parexel Major Business
        2.5.3 Parexel Clinical Trial Imaging Product and Solutions
        2.5.4 Parexel Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.5.5 Parexel Recent Developments and Future Plans
    2.6 BioTelemetry
        2.6.1 BioTelemetry Details
        2.6.2 BioTelemetry Major Business
        2.6.3 BioTelemetry Clinical Trial Imaging Product and Solutions
        2.6.4 BioTelemetry Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.6.5 BioTelemetry Recent Developments and Future Plans
    2.7 ProScan Imaging
        2.7.1 ProScan Imaging Details
        2.7.2 ProScan Imaging Major Business
        2.7.3 ProScan Imaging Clinical Trial Imaging Product and Solutions
        2.7.4 ProScan Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.7.5 ProScan Imaging Recent Developments and Future Plans
    2.8 Imaging Endpoints
        2.8.1 Imaging Endpoints Details
        2.8.2 Imaging Endpoints Major Business
        2.8.3 Imaging Endpoints Clinical Trial Imaging Product and Solutions
        2.8.4 Imaging Endpoints Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.8.5 Imaging Endpoints Recent Developments and Future Plans
    2.9 Radiant Sage
        2.9.1 Radiant Sage Details
        2.9.2 Radiant Sage Major Business
        2.9.3 Radiant Sage Clinical Trial Imaging Product and Solutions
        2.9.4 Radiant Sage Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.9.5 Radiant Sage Recent Developments and Future Plans
    2.10 Micron, Inc.
        2.10.1 Micron, Inc. Details
        2.10.2 Micron, Inc. Major Business
        2.10.3 Micron, Inc. Clinical Trial Imaging Product and Solutions
        2.10.4 Micron, Inc. Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.10.5 Micron, Inc. Recent Developments and Future Plans
    2.11 Intrinsic Imaging
        2.11.1 Intrinsic Imaging Details
        2.11.2 Intrinsic Imaging Major Business
        2.11.3 Intrinsic Imaging Clinical Trial Imaging Product and Solutions
        2.11.4 Intrinsic Imaging Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.11.5 Intrinsic Imaging Recent Developments and Future Plans
    2.12 Median Technologies
        2.12.1 Median Technologies Details
        2.12.2 Median Technologies Major Business
        2.12.3 Median Technologies Clinical Trial Imaging Product and Solutions
        2.12.4 Median Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.12.5 Median Technologies Recent Developments and Future Plans
    2.13 Cardiovascular Imaging Technologies
        2.13.1 Cardiovascular Imaging Technologies Details
        2.13.2 Cardiovascular Imaging Technologies Major Business
        2.13.3 Cardiovascular Imaging Technologies Clinical Trial Imaging Product and Solutions
        2.13.4 Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.13.5 Cardiovascular Imaging Technologies Recent Developments and Future Plans
    2.14 Banook Medical
        2.14.1 Banook Medical Details
        2.14.2 Banook Medical Major Business
        2.14.3 Banook Medical Clinical Trial Imaging Product and Solutions
        2.14.4 Banook Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.14.5 Banook Medical Recent Developments and Future Plans
    2.15 IXICO
        2.15.1 IXICO Details
        2.15.2 IXICO Major Business
        2.15.3 IXICO Clinical Trial Imaging Product and Solutions
        2.15.4 IXICO Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.15.5 IXICO Recent Developments and Future Plans
    2.16 Tigermed
        2.16.1 Tigermed Details
        2.16.2 Tigermed Major Business
        2.16.3 Tigermed Clinical Trial Imaging Product and Solutions
        2.16.4 Tigermed Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.16.5 Tigermed Recent Developments and Future Plans
    2.17 Runda Medical
        2.17.1 Runda Medical Details
        2.17.2 Runda Medical Major Business
        2.17.3 Runda Medical Clinical Trial Imaging Product and Solutions
        2.17.4 Runda Medical Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.17.5 Runda Medical Recent Developments and Future Plans
    2.18 Konica Minolta
        2.18.1 Konica Minolta Details
        2.18.2 Konica Minolta Major Business
        2.18.3 Konica Minolta Clinical Trial Imaging Product and Solutions
        2.18.4 Konica Minolta Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.18.5 Konica Minolta Recent Developments and Future Plans
    2.19 Keosys
        2.19.1 Keosys Details
        2.19.2 Keosys Major Business
        2.19.3 Keosys Clinical Trial Imaging Product and Solutions
        2.19.4 Keosys Clinical Trial Imaging Revenue, Gross Margin and Market Share (2020-2025)
        2.19.5 Keosys Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Clinical Trial Imaging Revenue and Share by Players (2020-2025)
    3.2 Market Share Analysis (2024)
        3.2.1 Market Share of Clinical Trial Imaging by Company Revenue
        3.2.2 Top 3 Clinical Trial Imaging Players Market Share in 2024
        3.2.3 Top 6 Clinical Trial Imaging Players Market Share in 2024
    3.3 Clinical Trial Imaging Market: Overall Company Footprint Analysis
        3.3.1 Clinical Trial Imaging Market: Region Footprint
        3.3.2 Clinical Trial Imaging Market: Company Product Type Footprint
        3.3.3 Clinical Trial Imaging Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Clinical Trial Imaging Consumption Value and Market Share by Type (2020-2025)
    4.2 Global Clinical Trial Imaging Market Forecast by Type (2026-2031)

5 Market Size Segment by Application
    5.1 Global Clinical Trial Imaging Consumption Value Market Share by Application (2020-2025)
    5.2 Global Clinical Trial Imaging Market Forecast by Application (2026-2031)

6 North America
    6.1 North America Clinical Trial Imaging Consumption Value by Type (2020-2031)
    6.2 North America Clinical Trial Imaging Market Size by Application (2020-2031)
    6.3 North America Clinical Trial Imaging Market Size by Country
        6.3.1 North America Clinical Trial Imaging Consumption Value by Country (2020-2031)
        6.3.2 United States Clinical Trial Imaging Market Size and Forecast (2020-2031)
        6.3.3 Canada Clinical Trial Imaging Market Size and Forecast (2020-2031)
        6.3.4 Mexico Clinical Trial Imaging Market Size and Forecast (2020-2031)

7 Europe
    7.1 Europe Clinical Trial Imaging Consumption Value by Type (2020-2031)
    7.2 Europe Clinical Trial Imaging Consumption Value by Application (2020-2031)
    7.3 Europe Clinical Trial Imaging Market Size by Country
        7.3.1 Europe Clinical Trial Imaging Consumption Value by Country (2020-2031)
        7.3.2 Germany Clinical Trial Imaging Market Size and Forecast (2020-2031)
        7.3.3 France Clinical Trial Imaging Market Size and Forecast (2020-2031)
        7.3.4 United Kingdom Clinical Trial Imaging Market Size and Forecast (2020-2031)
        7.3.5 Russia Clinical Trial Imaging Market Size and Forecast (2020-2031)
        7.3.6 Italy Clinical Trial Imaging Market Size and Forecast (2020-2031)

8 Asia-Pacific
    8.1 Asia-Pacific Clinical Trial Imaging Consumption Value by Type (2020-2031)
    8.2 Asia-Pacific Clinical Trial Imaging Consumption Value by Application (2020-2031)
    8.3 Asia-Pacific Clinical Trial Imaging Market Size by Region
        8.3.1 Asia-Pacific Clinical Trial Imaging Consumption Value by Region (2020-2031)
        8.3.2 China Clinical Trial Imaging Market Size and Forecast (2020-2031)
        8.3.3 Japan Clinical Trial Imaging Market Size and Forecast (2020-2031)
        8.3.4 South Korea Clinical Trial Imaging Market Size and Forecast (2020-2031)
        8.3.5 India Clinical Trial Imaging Market Size and Forecast (2020-2031)
        8.3.6 Southeast Asia Clinical Trial Imaging Market Size and Forecast (2020-2031)
        8.3.7 Australia Clinical Trial Imaging Market Size and Forecast (2020-2031)

9 South America
    9.1 South America Clinical Trial Imaging Consumption Value by Type (2020-2031)
    9.2 South America Clinical Trial Imaging Consumption Value by Application (2020-2031)
    9.3 South America Clinical Trial Imaging Market Size by Country
        9.3.1 South America Clinical Trial Imaging Consumption Value by Country (2020-2031)
        9.3.2 Brazil Clinical Trial Imaging Market Size and Forecast (2020-2031)
        9.3.3 Argentina Clinical Trial Imaging Market Size and Forecast (2020-2031)

10 Middle East & Africa
    10.1 Middle East & Africa Clinical Trial Imaging Consumption Value by Type (2020-2031)
    10.2 Middle East & Africa Clinical Trial Imaging Consumption Value by Application (2020-2031)
    10.3 Middle East & Africa Clinical Trial Imaging Market Size by Country
        10.3.1 Middle East & Africa Clinical Trial Imaging Consumption Value by Country (2020-2031)
        10.3.2 Turkey Clinical Trial Imaging Market Size and Forecast (2020-2031)
        10.3.3 Saudi Arabia Clinical Trial Imaging Market Size and Forecast (2020-2031)
        10.3.4 UAE Clinical Trial Imaging Market Size and Forecast (2020-2031)

11 Market Dynamics
    11.1 Clinical Trial Imaging Market Drivers
    11.2 Clinical Trial Imaging Market Restraints
    11.3 Clinical Trial Imaging Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Clinical Trial Imaging Industry Chain
    12.2 Clinical Trial Imaging Upstream Analysis
    12.3 Clinical Trial Imaging Midstream Analysis
    12.4 Clinical Trial Imaging Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Clinical Trial Imaging Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Table 2. Global Clinical Trial Imaging Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Table 3. Global Clinical Trial Imaging Consumption Value by Region (2020-2025) & (USD Million)
 Table 4. Global Clinical Trial Imaging Consumption Value by Region (2026-2031) & (USD Million)
 Table 5. ICON Company Information, Head Office, and Major Competitors
 Table 6. ICON Major Business
 Table 7. ICON Clinical Trial Imaging Product and Solutions
 Table 8. ICON Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 9. ICON Recent Developments and Future Plans
 Table 10. ERT Company Information, Head Office, and Major Competitors
 Table 11. ERT Major Business
 Table 12. ERT Clinical Trial Imaging Product and Solutions
 Table 13. ERT Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 14. ERT Recent Developments and Future Plans
 Table 15. McLaren Company Information, Head Office, and Major Competitors
 Table 16. McLaren Major Business
 Table 17. McLaren Clinical Trial Imaging Product and Solutions
 Table 18. McLaren Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 19. Bioclinica Company Information, Head Office, and Major Competitors
 Table 20. Bioclinica Major Business
 Table 21. Bioclinica Clinical Trial Imaging Product and Solutions
 Table 22. Bioclinica Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 23. Bioclinica Recent Developments and Future Plans
 Table 24. Parexel Company Information, Head Office, and Major Competitors
 Table 25. Parexel Major Business
 Table 26. Parexel Clinical Trial Imaging Product and Solutions
 Table 27. Parexel Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 28. Parexel Recent Developments and Future Plans
 Table 29. BioTelemetry Company Information, Head Office, and Major Competitors
 Table 30. BioTelemetry Major Business
 Table 31. BioTelemetry Clinical Trial Imaging Product and Solutions
 Table 32. BioTelemetry Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 33. BioTelemetry Recent Developments and Future Plans
 Table 34. ProScan Imaging Company Information, Head Office, and Major Competitors
 Table 35. ProScan Imaging Major Business
 Table 36. ProScan Imaging Clinical Trial Imaging Product and Solutions
 Table 37. ProScan Imaging Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 38. ProScan Imaging Recent Developments and Future Plans
 Table 39. Imaging Endpoints Company Information, Head Office, and Major Competitors
 Table 40. Imaging Endpoints Major Business
 Table 41. Imaging Endpoints Clinical Trial Imaging Product and Solutions
 Table 42. Imaging Endpoints Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 43. Imaging Endpoints Recent Developments and Future Plans
 Table 44. Radiant Sage Company Information, Head Office, and Major Competitors
 Table 45. Radiant Sage Major Business
 Table 46. Radiant Sage Clinical Trial Imaging Product and Solutions
 Table 47. Radiant Sage Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 48. Radiant Sage Recent Developments and Future Plans
 Table 49. Micron, Inc. Company Information, Head Office, and Major Competitors
 Table 50. Micron, Inc. Major Business
 Table 51. Micron, Inc. Clinical Trial Imaging Product and Solutions
 Table 52. Micron, Inc. Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 53. Micron, Inc. Recent Developments and Future Plans
 Table 54. Intrinsic Imaging Company Information, Head Office, and Major Competitors
 Table 55. Intrinsic Imaging Major Business
 Table 56. Intrinsic Imaging Clinical Trial Imaging Product and Solutions
 Table 57. Intrinsic Imaging Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 58. Intrinsic Imaging Recent Developments and Future Plans
 Table 59. Median Technologies Company Information, Head Office, and Major Competitors
 Table 60. Median Technologies Major Business
 Table 61. Median Technologies Clinical Trial Imaging Product and Solutions
 Table 62. Median Technologies Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 63. Median Technologies Recent Developments and Future Plans
 Table 64. Cardiovascular Imaging Technologies Company Information, Head Office, and Major Competitors
 Table 65. Cardiovascular Imaging Technologies Major Business
 Table 66. Cardiovascular Imaging Technologies Clinical Trial Imaging Product and Solutions
 Table 67. Cardiovascular Imaging Technologies Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 68. Cardiovascular Imaging Technologies Recent Developments and Future Plans
 Table 69. Banook Medical Company Information, Head Office, and Major Competitors
 Table 70. Banook Medical Major Business
 Table 71. Banook Medical Clinical Trial Imaging Product and Solutions
 Table 72. Banook Medical Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 73. Banook Medical Recent Developments and Future Plans
 Table 74. IXICO Company Information, Head Office, and Major Competitors
 Table 75. IXICO Major Business
 Table 76. IXICO Clinical Trial Imaging Product and Solutions
 Table 77. IXICO Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 78. IXICO Recent Developments and Future Plans
 Table 79. Tigermed Company Information, Head Office, and Major Competitors
 Table 80. Tigermed Major Business
 Table 81. Tigermed Clinical Trial Imaging Product and Solutions
 Table 82. Tigermed Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 83. Tigermed Recent Developments and Future Plans
 Table 84. Runda Medical Company Information, Head Office, and Major Competitors
 Table 85. Runda Medical Major Business
 Table 86. Runda Medical Clinical Trial Imaging Product and Solutions
 Table 87. Runda Medical Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 88. Runda Medical Recent Developments and Future Plans
 Table 89. Konica Minolta Company Information, Head Office, and Major Competitors
 Table 90. Konica Minolta Major Business
 Table 91. Konica Minolta Clinical Trial Imaging Product and Solutions
 Table 92. Konica Minolta Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 93. Konica Minolta Recent Developments and Future Plans
 Table 94. Keosys Company Information, Head Office, and Major Competitors
 Table 95. Keosys Major Business
 Table 96. Keosys Clinical Trial Imaging Product and Solutions
 Table 97. Keosys Clinical Trial Imaging Revenue (USD Million), Gross Margin and Market Share (2020-2025)
 Table 98. Keosys Recent Developments and Future Plans
 Table 99. Global Clinical Trial Imaging Revenue (USD Million) by Players (2020-2025)
 Table 100. Global Clinical Trial Imaging Revenue Share by Players (2020-2025)
 Table 101. Breakdown of Clinical Trial Imaging by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 102. Market Position of Players in Clinical Trial Imaging, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
 Table 103. Head Office of Key Clinical Trial Imaging Players
 Table 104. Clinical Trial Imaging Market: Company Product Type Footprint
 Table 105. Clinical Trial Imaging Market: Company Product Application Footprint
 Table 106. Clinical Trial Imaging New Market Entrants and Barriers to Market Entry
 Table 107. Clinical Trial Imaging Mergers, Acquisition, Agreements, and Collaborations
 Table 108. Global Clinical Trial Imaging Consumption Value (USD Million) by Type (2020-2025)
 Table 109. Global Clinical Trial Imaging Consumption Value Share by Type (2020-2025)
 Table 110. Global Clinical Trial Imaging Consumption Value Forecast by Type (2026-2031)
 Table 111. Global Clinical Trial Imaging Consumption Value by Application (2020-2025)
 Table 112. Global Clinical Trial Imaging Consumption Value Forecast by Application (2026-2031)
 Table 113. North America Clinical Trial Imaging Consumption Value by Type (2020-2025) & (USD Million)
 Table 114. North America Clinical Trial Imaging Consumption Value by Type (2026-2031) & (USD Million)
 Table 115. North America Clinical Trial Imaging Consumption Value by Application (2020-2025) & (USD Million)
 Table 116. North America Clinical Trial Imaging Consumption Value by Application (2026-2031) & (USD Million)
 Table 117. North America Clinical Trial Imaging Consumption Value by Country (2020-2025) & (USD Million)
 Table 118. North America Clinical Trial Imaging Consumption Value by Country (2026-2031) & (USD Million)
 Table 119. Europe Clinical Trial Imaging Consumption Value by Type (2020-2025) & (USD Million)
 Table 120. Europe Clinical Trial Imaging Consumption Value by Type (2026-2031) & (USD Million)
 Table 121. Europe Clinical Trial Imaging Consumption Value by Application (2020-2025) & (USD Million)
 Table 122. Europe Clinical Trial Imaging Consumption Value by Application (2026-2031) & (USD Million)
 Table 123. Europe Clinical Trial Imaging Consumption Value by Country (2020-2025) & (USD Million)
 Table 124. Europe Clinical Trial Imaging Consumption Value by Country (2026-2031) & (USD Million)
 Table 125. Asia-Pacific Clinical Trial Imaging Consumption Value by Type (2020-2025) & (USD Million)
 Table 126. Asia-Pacific Clinical Trial Imaging Consumption Value by Type (2026-2031) & (USD Million)
 Table 127. Asia-Pacific Clinical Trial Imaging Consumption Value by Application (2020-2025) & (USD Million)
 Table 128. Asia-Pacific Clinical Trial Imaging Consumption Value by Application (2026-2031) & (USD Million)
 Table 129. Asia-Pacific Clinical Trial Imaging Consumption Value by Region (2020-2025) & (USD Million)
 Table 130. Asia-Pacific Clinical Trial Imaging Consumption Value by Region (2026-2031) & (USD Million)
 Table 131. South America Clinical Trial Imaging Consumption Value by Type (2020-2025) & (USD Million)
 Table 132. South America Clinical Trial Imaging Consumption Value by Type (2026-2031) & (USD Million)
 Table 133. South America Clinical Trial Imaging Consumption Value by Application (2020-2025) & (USD Million)
 Table 134. South America Clinical Trial Imaging Consumption Value by Application (2026-2031) & (USD Million)
 Table 135. South America Clinical Trial Imaging Consumption Value by Country (2020-2025) & (USD Million)
 Table 136. South America Clinical Trial Imaging Consumption Value by Country (2026-2031) & (USD Million)
 Table 137. Middle East & Africa Clinical Trial Imaging Consumption Value by Type (2020-2025) & (USD Million)
 Table 138. Middle East & Africa Clinical Trial Imaging Consumption Value by Type (2026-2031) & (USD Million)
 Table 139. Middle East & Africa Clinical Trial Imaging Consumption Value by Application (2020-2025) & (USD Million)
 Table 140. Middle East & Africa Clinical Trial Imaging Consumption Value by Application (2026-2031) & (USD Million)
 Table 141. Middle East & Africa Clinical Trial Imaging Consumption Value by Country (2020-2025) & (USD Million)
 Table 142. Middle East & Africa Clinical Trial Imaging Consumption Value by Country (2026-2031) & (USD Million)
 Table 143. Global Key Players of Clinical Trial Imaging Upstream (Raw Materials)
 Table 144. Global Clinical Trial Imaging Typical Customers


List of Figures
 Figure 1. Clinical Trial Imaging Picture
 Figure 2. Global Clinical Trial Imaging Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
 Figure 3. Global Clinical Trial Imaging Consumption Value Market Share by Type in 2024
 Figure 4. In-house Imaging Service
 Figure 5. Central Imaging Service
 Figure 6. Global Clinical Trial Imaging Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
 Figure 7. Clinical Trial Imaging Consumption Value Market Share by Application in 2024
 Figure 8. Pharmaceutical Companies Picture
 Figure 9. Biotechnology Companies Picture
 Figure 10. Academic Institutes Picture
 Figure 11. Others Picture
 Figure 12. Global Clinical Trial Imaging Consumption Value, (USD Million): 2020 & 2024 & 2031
 Figure 13. Global Clinical Trial Imaging Consumption Value and Forecast (2020-2031) & (USD Million)
 Figure 14. Global Market Clinical Trial Imaging Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
 Figure 15. Global Clinical Trial Imaging Consumption Value Market Share by Region (2020-2031)
 Figure 16. Global Clinical Trial Imaging Consumption Value Market Share by Region in 2024
 Figure 17. North America Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 18. Europe Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 19. Asia-Pacific Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 20. South America Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 21. Middle East & Africa Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 22. Company Three Recent Developments and Future Plans
 Figure 23. Global Clinical Trial Imaging Revenue Share by Players in 2024
 Figure 24. Clinical Trial Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
 Figure 25. Market Share of Clinical Trial Imaging by Player Revenue in 2024
 Figure 26. Top 3 Clinical Trial Imaging Players Market Share in 2024
 Figure 27. Top 6 Clinical Trial Imaging Players Market Share in 2024
 Figure 28. Global Clinical Trial Imaging Consumption Value Share by Type (2020-2025)
 Figure 29. Global Clinical Trial Imaging Market Share Forecast by Type (2026-2031)
 Figure 30. Global Clinical Trial Imaging Consumption Value Share by Application (2020-2025)
 Figure 31. Global Clinical Trial Imaging Market Share Forecast by Application (2026-2031)
 Figure 32. North America Clinical Trial Imaging Consumption Value Market Share by Type (2020-2031)
 Figure 33. North America Clinical Trial Imaging Consumption Value Market Share by Application (2020-2031)
 Figure 34. North America Clinical Trial Imaging Consumption Value Market Share by Country (2020-2031)
 Figure 35. United States Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 36. Canada Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 37. Mexico Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 38. Europe Clinical Trial Imaging Consumption Value Market Share by Type (2020-2031)
 Figure 39. Europe Clinical Trial Imaging Consumption Value Market Share by Application (2020-2031)
 Figure 40. Europe Clinical Trial Imaging Consumption Value Market Share by Country (2020-2031)
 Figure 41. Germany Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 42. France Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 43. United Kingdom Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 44. Russia Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 45. Italy Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 46. Asia-Pacific Clinical Trial Imaging Consumption Value Market Share by Type (2020-2031)
 Figure 47. Asia-Pacific Clinical Trial Imaging Consumption Value Market Share by Application (2020-2031)
 Figure 48. Asia-Pacific Clinical Trial Imaging Consumption Value Market Share by Region (2020-2031)
 Figure 49. China Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 50. Japan Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 51. South Korea Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 52. India Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 53. Southeast Asia Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 54. Australia Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 55. South America Clinical Trial Imaging Consumption Value Market Share by Type (2020-2031)
 Figure 56. South America Clinical Trial Imaging Consumption Value Market Share by Application (2020-2031)
 Figure 57. South America Clinical Trial Imaging Consumption Value Market Share by Country (2020-2031)
 Figure 58. Brazil Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 59. Argentina Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 60. Middle East & Africa Clinical Trial Imaging Consumption Value Market Share by Type (2020-2031)
 Figure 61. Middle East & Africa Clinical Trial Imaging Consumption Value Market Share by Application (2020-2031)
 Figure 62. Middle East & Africa Clinical Trial Imaging Consumption Value Market Share by Country (2020-2031)
 Figure 63. Turkey Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 64. Saudi Arabia Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 65. UAE Clinical Trial Imaging Consumption Value (2020-2031) & (USD Million)
 Figure 66. Clinical Trial Imaging Market Drivers
 Figure 67. Clinical Trial Imaging Market Restraints
 Figure 68. Clinical Trial Imaging Market Trends
 Figure 69. Porters Five Forces Analysis
 Figure 70. Clinical Trial Imaging Industrial Chain
 Figure 71. Methodology
 Figure 72. Research Process and Data Source

Companies Mentioned

ICON
ERT
McLaren
Bioclinica
Parexel
BioTelemetry
ProScan Imaging
Imaging Endpoints
Radiant Sage
Micron, Inc.
Intrinsic Imaging
Median Technologies
Cardiovascular Imaging Technologies
Banook Medical
IXICO
Tigermed
Runda Medical
Konica Minolta
Keosys